4.5 Article

NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody

Related references

Note: Only part of the references are listed.
Article Immunology

Acquisition of regulatory function by human CD8+ T cells treated with anti-CD3 antibody requires TNF

Vitaly Ablamunits et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′)2

Jianmei W. Leavenworth et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Natural Killer Cell Signal Integration Balances Synapse Symmetry and Migration

Fiona J. Culley et al.

PLOS BIOLOGY (2009)

Article Endocrinology & Metabolism

Human Regulatory CD8(+) T Cell The Involvement of Cytokines

Vitaly Ablamunits et al.

Immunology of Diabetes V: From Bench to Bedside (2008)

Article Immunology

CD8+regulatory T cells in persistent human viral infections

Eva Billerbeck et al.

HUMAN IMMUNOLOGY (2008)

Article Immunology

Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis

Jorge Correale et al.

JOURNAL OF NEUROIMMUNOLOGY (2008)

Article Multidisciplinary Sciences

Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease

Linrong Lu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Gastroenterology & Hepatology

Regulatory T cells in viral hepatitis

Eva Billerbeck et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)

Article Multidisciplinary Sciences

Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4

Simone A. Joosten et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Medicine, Research & Experimental

TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs

B Bisikirska et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Medicine, General & Internal

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

KC Herold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Immunology

Conservation and variation in human and common chimpanzee CD94 and NKG2 genes

BP Shum et al.

JOURNAL OF IMMUNOLOGY (2002)